. 2018 Dec 7;58(4):683–691. doi: 10.1093/rheumatology/key352
© The Author(s) 2018. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For permissions, please email: journals.permissions@oup.com
This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model)
Fig. 1.
Study flowchart for the primary objective
bDMARD: biologic DMARD.